GlassScriptPhysician profile
Tyler Madison Gaines
NPI 1861017402
$3,472.34
in general payments reported to CMS, 2019-2025
9 companies · $23.46 in 2025
The $23.46 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $833 · 2023: $2,212 · 2024: $153 · 2025: $23.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,291 · Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,290.55 |
| Food and Beverage | $1,098.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,145.67 | 2021-2025 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Ams 700 |
| Medtronic, INC. | $516.04 | 2021-2023 | Interstim |
| Teleflex LLC | $258.96 | 2022-2024 | Urolift |
| Coloplast Corp | $127.04 | 2022 | |
| Ambu INC. | $123.33 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $117.94 | 2022-2023 | |
| Myriad Genetic Laboratories, INC. | $111.90 | 2023 | Prolaris |
| Dendreon Pharmaceuticals LLC | $39.45 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Gaines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.